Clinical Trials

248 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00509431 2020-07-31

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

19 enrolled

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00543504 2020-06-30

Bevacizumab in Multiple Phase I Combinations

343 enrolled

Advanced Cancer

NCT03403049 2020-04-22

Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer

14 enrolled

Neoplasms, Pancreatic Neoplasms

NCT00966472 2020-04-21

Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC

24 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

NCT02013219 2020-04-21

A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC)

52 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00581789 2019-11-19

Erlotinib and Sunitinib in NSCLC

11 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00848718 2019-11-12

MK-2206-003

77 enrolled 24 charts

Neoplasms

NCT01545947 2019-11-12

Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer

76 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT01116336 2018-12-05

Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & Neck

25 enrolled

Head & Neck

Head and Neck Neoplasms

NCT01967095 2018-11-13

Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer

53 enrolled

EGFR-Mutant Lung Cancer

NCT01561014 2018-07-02

Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

9 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT00565487 2018-05-21

Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer

15 enrolled

Pancreatic Neoplasms

NCT00085553 2018-05-18

Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid Tumors

29 enrolled

Solid Neoplasm

NCT01998126 2018-04-02

Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer

14 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00139620 2018-02-08

A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function

39 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT00033241 2018-01-10

Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors

Pancreatic Neoplasms

NCT00998036 2017-12-13

Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors

9 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01472016 2017-11-21

Study of ABT-700 in Subjects With Advanced Solid Tumors

74 enrolled

Neoplasms

NCT01009073 2017-11-20

A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects

51 enrolled

Other solid neoplasm

Solid Tumors

NCT00619424 2017-11-17

A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors

58 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01192165 2017-11-13

Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel

169 enrolled

Neoplasms

NCT01650506 2017-08-30

Study of Erlotinib and Metformin in Triple Negative Breast Cancer

8 enrolled

Breast

Breast Neoplasms

NCT00987766 2017-07-02

Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer

28 enrolled

Bile Duct Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Pancreatic Neoplasms

NCT01069757 2017-03-15

A Study of ARQ 197 in Combination With Erlotinib

16 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01251796 2017-03-15

A Study of ARQ 197 in Combination With Erlotinib

9 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00761345 2017-03-07

Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer

27 enrolled 6 charts

Pancreatic Neoplasms

NCT00444015 2017-02-23

Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)

34 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01287546 2017-02-15

A Study of LY2875358 in Participants With Advanced Cancer

117 enrolled

Advanced Cancer

NCT01482377 2017-01-27

A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin

145 enrolled

Neoplasms

NCT00975182 2016-11-02

A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors

58 enrolled

Non-Squamous Non-Small Cell Lung Cancer, Solid Cancers

NCT01839955 2016-10-31

Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer

12 enrolled